isoniazid has been researched along with pentacyanoferrate (ii) in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| da Costa, AL; de Souza, ON; Dorn, M; Pauli, I; Schroeder, EK; Zhan, CG | 1 |
| Basso, LA; Calixto, JB; Campos, MM; de França Lopes, LG; Dos Santos Junior, A; Dos Santos, AJ; Rodrigues-Junior, VS; Santos, DS; Schneider, CZ; Sousa, EH; Souto, AA | 1 |
2 other study(ies) available for isoniazid and pentacyanoferrate (ii)
| Article | Year |
|---|---|
Conformational changes in 2-trans-enoyl-ACP (CoA) reductase (InhA) from M. tuberculosis induced by an inorganic complex: a molecular dynamics simulation study.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; Catalytic Domain; Drug Design; Ferrous Compounds; Isoniazid; Kinetics; Molecular Dynamics Simulation; Mycobacterium tuberculosis; Oxidoreductases; Protein Binding; Protein Conformation | 2012 |
Activity of IQG-607, a new orally active compound, in a murine model of Mycobacterium tuberculosis infection.
Topics: Animals; Antitubercular Agents; Bacterial Load; Disease Models, Animal; Drug Evaluation, Preclinical; Ferrous Compounds; Isoniazid; Lung; Lung Diseases; Male; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxadiazoles; Tuberculosis | 2012 |